ZBH

AI Research

$0.24 dividend declared; Hold consensus amid 5.4% FY26 growth forecast and stagnant ASPs

Zimmer Biomet announced a $0.24 quarterly dividend with an ex-date of March 31, 2026, while trading at ~$93 with an $18.26B market cap. The stock faces mixed analyst views with a median price target of $110, reflecting muted revenue growth and challenging operational conditions including stagnant average selling prices. Q1 2026 earnings are due May 5, 2026, with FY26 growth estimated at only 5.4% year-over-year.